NCT04421287

Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With SCAD

Clinical Study on the Effect of Zhenyuan Capsule on Cardiopulmonary Function in Patients With Stable Coronary Heart Disease With Qi Deficiency and Blood Stasis

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

A randomized, double-blind, placebo trial was adopted, and cardiopulmonary exercise load test (CPET) was used to detect peak oxygen uptake (PeakVO2) and exercise metabolic equivalent (METs) to confirm the clinical effect of Zhenyuan capsule on improving cardiopulmonary endurance in patients with coronary heart disease of qi deficiency and blood stasis.

Conditions

• Stable Coronary Heart Disease

Interventions

Type	Name	Description
DRUG	Zhenyuan capsule	0.25g/ tablets, 2 tablets / TID, for 12 weeks

Timeline

• Start date: 2020-06-01
• Primary completion: 2021-07-01
• Completion: 2021-12-01
• First posted: 2020-06-09
• Last updated: 2020-06-09

Locations

1 site across 1 country: China